Pocket-Sized defibrillators for volunteers could revolutionize cardiac arrest response

NCT ID NCT07042061

Not yet recruiting Disease control Sponsor: Singapore General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether giving volunteer community responders a small, portable defibrillator (about the size of a chocolate bar) helps them treat people having a cardiac arrest outside the hospital. Around 1,000 volunteers in Singapore will carry the device for up to a year and use it if alerted to a nearby cardiac arrest. The main goal is to see if this approach is practical and acceptable, and whether it leads to more people being shocked with a defibrillator sooner.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: mobile external automated defibrillator (mAED)
What this could lead to: If it works, this could show that equipping community volunteers with a small, portable defibrillator helps more cardiac arrest patients get shocked faster, potentially saving more lives.
What could go wrong: This is a feasibility study, not a large-scale effectiveness trial. It is too early to know if the approach actually improves survival. Volunteers may face challenges carrying the device or reaching the scene in time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OUT-OF-HOSPITAL CARDIAC ARREST (OHCA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiac arrest Out-of-Hospital Cardiac Arrest sudden cardiac arrest

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OUT-OF-HOSPITAL CARDIAC ARREST (OHCA)

More trials for these conditions

Other studies related to the condition(s) this trial covers.